
Scholar Rock Holding Corporation: shareholders and insiders
Price
$48.13
November 20, 2026Market cap $5.9B
What Ploutos Investor adds for Scholar Rock
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 22, 2025 to Oct 27, 2026, from their own Form 4 filings.
Bought on the market
$12M
1 person
Sold on the market
$19M
13 people
From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan45%
- The rest55%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $12M by 1 person·sold $13M by 13 people
- 2025: no buys, sold $6.2M by 2 people
- 2026: bought $12M by 1 person, sold $13M by 13 people
- Oct 26, 2026Srinivas AkkarajuDirectorKind
- Oct 26, 2026Srinivas AkkarajuDirectorKind
- Oct 23, 2026Srinivas AkkarajuDirectorKind
- Oct 23, 2026Srinivas AkkarajuDirectorKind
- Oct 23, 2026Srinivas AkkarajuDirectorKind
- Oct 23, 2026Srinivas AkkarajuDirectorKind
- Sep 24, 2026Keith WoodsChief Operating OfficerKind
- Sep 21, 2026David HallalChief Executive OfficerKind
- Jul 1, 2026Jeffrey S. FlierDirectorKind10b5-1
- Jul 1, 2026Jeffrey S. FlierDirectorKind10b5-1
- Jul 1, 2026Jeffrey S. FlierDirectorKind10b5-1
- Jul 1, 2026Michael GilmanDirectorKind10b5-1
- Jul 1, 2026Michael GilmanDirectorKind10b5-1
- Jul 1, 2026Michael GilmanDirectorKind10b5-1
- Jul 1, 2026Kristina BurowDirectorKind10b5-1
- Jul 1, 2026Kristina BurowDirectorKind10b5-1
- Jul 1, 2026Joshua ReedDirectorKind10b5-1
- Jul 1, 2026Joshua ReedDirectorKind10b5-1
- Jul 1, 2026Katie PengDirectorKind10b5-1
- Jul 1, 2026Katie PengDirectorKind10b5-1
- Jul 1, 2026Katie PengDirectorKind10b5-1
- Jun 4, 2026Jeffrey S. FlierDirectorKind
- Jun 4, 2026Joshua ReedDirectorKind
- Jun 4, 2026Richard BrudnickDirectorKind
- Jun 4, 2026Kristina BurowDirectorKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Srinivas AkkarajuDirector | 49.0K | $41.59 | $2.0M | Form 4 | |
| Oct 26, 2026 | Srinivas AkkarajuDirector | 98.0K | $41.59 | $4.1M | Form 4 | |
| Oct 23, 2026 | Srinivas AkkarajuDirector | 47.0K | $41.31 | $1.9M | Form 4 | |
| Oct 23, 2026 | Srinivas AkkarajuDirector | 94.0K | $41.31 | $3.9M | Form 4 | |
| Oct 23, 2026 | Srinivas AkkarajuDirector | 500 | $41.82 | $20.9K | Form 4 | |
| Oct 23, 2026 | Srinivas AkkarajuDirector | 1,000 | $41.82 | $41.8K | Form 4 | |
| Sep 24, 2026 | Keith WoodsChief Operating Officer | 48.0K | – | – | Form 4 | |
| Sep 21, 2026 | David HallalChief Executive Officer | 36.7K | – | – | Form 4 | |
| Jul 1, 2026 | Jeffrey S. FlierDirector | 10b5-1 | 1,568 | $53.53 | $83.9K | Form 4 |
| Jul 1, 2026 | Jeffrey S. FlierDirector | 10b5-1 | 1,470 | $54.24 | $79.7K | Form 4 |
| Jul 1, 2026 | Jeffrey S. FlierDirector | 10b5-1 | 15 | $54.88 | $823 | Form 4 |
| Jul 1, 2026 | Michael GilmanDirector | 10b5-1 | 1,346 | $53.54 | $72.1K | Form 4 |
| Jul 1, 2026 | Michael GilmanDirector | 10b5-1 | 1,155 | $54.23 | $62.6K | Form 4 |
| Jul 1, 2026 | Michael GilmanDirector | 10b5-1 | 43 | $54.81 | $2.4K | Form 4 |
| Jul 1, 2026 | Kristina BurowDirector | 10b5-1 | 2,105 | $53.49 | $112.6K | Form 4 |
| Jul 1, 2026 | Kristina BurowDirector | 10b5-1 | 948 | $54.28 | $51.5K | Form 4 |
| Jul 1, 2026 | Joshua ReedDirector | 10b5-1 | 2,105 | $53.50 | $112.6K | Form 4 |
| Jul 1, 2026 | Joshua ReedDirector | 10b5-1 | 948 | $54.28 | $51.5K | Form 4 |
| Jul 1, 2026 | Katie PengDirector | 10b5-1 | 2,988 | $53.56 | $160.0K | Form 4 |
| Jul 1, 2026 | Katie PengDirector | 10b5-1 | 2,437 | $54.25 | $132.2K | Form 4 |
| Jul 1, 2026 | Katie PengDirector | 10b5-1 | 21 | $54.96 | $1.2K | Form 4 |
| Jun 4, 2026 | Jeffrey S. FlierDirector | 6,839 | – | – | Form 4 | |
| Jun 4, 2026 | Joshua ReedDirector | 6,839 | – | – | Form 4 | |
| Jun 4, 2026 | Richard BrudnickDirector | 6,839 | – | – | Form 4 | |
| Jun 4, 2026 | Kristina BurowDirector | 6,839 | – | – | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 8, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by SRRK's officers and directors from 2018 up to November 21, 2025, 8 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 3 more, back to 2018
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- FMRwith 1 more personShare of class15.0%
- Invus Public Equities, L.P.with 4 more personsShare of class8.00%
- Samsara BioCapital, L.P.with 4 more personsShare of class7.20%
- Wellington Management Group LLPwith 3 more personsShare of class5.60%
- T. Rowe Price Associates, Inc.Share of class5.40%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| FMRwith 1 more person | 15.0% | 14.11M | Feb 12, 2025 | 13G/A | |
| Invus Public Equities, L.P.with 4 more persons | 8.00% | 9.58M | Aug 13, 20262 filings since Feb 12, 2025 | 13G/A | |
| Samsara BioCapital, L.P.with 4 more persons | 7.20% | 6.99M | Oct 7, 2025 | 13D/A | |
| Wellington Management Group LLPwith 3 more persons | 5.60% | 5.76M | Feb 10, 2026 | 13G | |
| T. Rowe Price Associates, Inc. | 5.40% | 6.21M | May 15, 20263 filings since Aug 14, 2025 | 13G/A |
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter+531%
- Point72 (Cohen)In the quarter
- Millennium Mgmt (Englander)In the quarter+14%
- D.E. ShawIn the quarter-37%
- Renaissance TechnologiesIn the quarter-32%
- AQR CapitalIn the quarter+35%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 2.09M | +531% | $101M | 0.06% |
| Point72 (Cohen) | 437.4K | $21M | 0.03% | |
| Millennium Mgmt (Englander) | 20.6K | +14% | $1.0M | 0.00% |
| D.E. Shaw | 154.1K | -37% | $7.4M | 0.00% |
| Renaissance Technologies | 62.5K | -32% | $3.0M | 0.00% |
| AQR Capital | 335.0K | +35% | $16M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 18.2% of its shares outstanding were held short, -2.4% since the report before.
- Shares held short
- 22.18M
- 18.2%
- Since the report before22.72M on Sep 30, 2026
- -2.4%
- 12.7
- 1.74M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 96%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 10.31M
- Nov 15, 2023: Shares held short 10.30M
- Nov 30, 2023: Shares held short 10.11M
- Dec 15, 2023: Shares held short 10.23M
- Dec 29, 2023: Shares held short 11.34M
- Jan 12, 2024: Shares held short 11.55M
- Jan 31, 2024: Shares held short 11.40M
- Feb 15, 2024: Shares held short 11.38M
- Feb 29, 2024: Shares held short 11.17M
- Mar 15, 2024: Shares held short 10.54M
- Mar 28, 2024: Shares held short 12.52M
- Apr 15, 2024: Shares held short 12.69M
- Apr 30, 2024: Shares held short 13.38M
- May 15, 2024: Shares held short 13.33M
- May 31, 2024: Shares held short 14.00M
- Jun 14, 2024: Shares held short 13.95M
- Jun 28, 2024: Shares held short 13.36M
- Jul 15, 2024: Shares held short 13.82M
- Jul 31, 2024: Shares held short 14.44M
- Aug 15, 2024: Shares held short 14.91M
- Aug 30, 2024: Shares held short 15.91M
- Sep 13, 2024: Shares held short 16.62M
- Sep 30, 2024: Shares held short 16.52M
- Oct 15, 2024: Shares held short 14.93M
- Oct 31, 2024: Shares held short 15.31M
- Nov 15, 2024: Shares held short 15.14M
- Nov 29, 2024: Shares held short 14.75M
- Dec 13, 2024: Shares held short 15.07M
- Dec 31, 2024: Shares held short 15.36M
- Jan 15, 2025: Shares held short 15.66M
- Jan 31, 2025: Shares held short 15.60M
- Feb 14, 2025: Shares held short 15.98M
- Feb 28, 2025: Shares held short 15.95M
- Mar 14, 2025: Shares held short 16.13M
- Mar 31, 2025: Shares held short 16.28M
- Apr 15, 2025: Shares held short 16.97M
- Apr 30, 2025: Shares held short 17.18M
- May 15, 2025: Shares held short 15.21M
- May 30, 2025: Shares held short 14.23M
- Jun 13, 2025: Shares held short 14.93M
- Jun 30, 2025: Shares held short 14.21M
- Jul 15, 2025: Shares held short 14.17M
- Jul 31, 2025: Shares held short 14.87M
- Aug 15, 2025: Shares held short 15.47M
- Aug 29, 2025: Shares held short 16.83M
- Sep 15, 2025: Shares held short 16.08M
- Sep 30, 2025: Shares held short 16.42M
- Oct 15, 2025: Shares held short 16.92M
- Oct 31, 2025: Shares held short 17.90M
- Nov 14, 2025: Shares held short 17.17M
- Nov 28, 2025: Shares held short 15.95M
- Dec 15, 2025: Shares held short 16.65M
- Dec 31, 2025: Shares held short 14.74M
- Jan 15, 2026: Shares held short 15.67M
- Jan 30, 2026: Shares held short 15.53M
- Feb 13, 2026: Shares held short 15.62M
- Feb 27, 2026: Shares held short 14.52M
- Mar 13, 2026: Shares held short 14.29M
- Mar 31, 2026: Shares held short 15.74M
- Apr 15, 2026: Shares held short 14.81M
- Apr 30, 2026: Shares held short 14.91M
- May 15, 2026: Shares held short 15.66M
- May 29, 2026: Shares held short 16.43M
- Jun 15, 2026: Shares held short 16.73M
- Jun 30, 2026: Shares held short 18.38M
- Jul 15, 2026: Shares held short 17.60M
- Jul 31, 2026: Shares held short 17.67M
- Aug 14, 2026: Shares held short 18.22M
- Aug 31, 2026: Shares held short 18.01M
- Sep 15, 2026: Shares held short 19.41M
- Sep 30, 2026: Shares held short 22.72M
- Oct 15, 2026: Shares held short 22.18M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading59.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 59.5% of the shares in the reported trades were short sales, against 71.7% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 59.5%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 71.7%
- Change
- -12.2 pts
- Short sales a dayon average, of 822.0K shares
- 489.4K
- More than atof 3,666 US-listed companies, same days
- 81%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 50.8%
- Oct 15, 2026: Short sales 52.8%
- Oct 16, 2026: Short sales 85.1%
- Oct 19, 2026: Short sales 83%
- Oct 20, 2026: Short sales 64.5%
- Oct 21, 2026: Short sales 87.4%
- Oct 22, 2026: Short sales 81.8%
- Oct 23, 2026: Short sales 57.6%
- Oct 26, 2026: Short sales 91.7%
- Oct 27, 2026: Short sales 84.6%
- Oct 28, 2026: Short sales 57.1%
- Oct 29, 2026: Short sales 48%
- Oct 30, 2026: Short sales 48.7%
- Nov 2, 2026: Short sales 69.9%
- Nov 3, 2026: Short sales 54.4%
- Nov 4, 2026: Short sales 85.2%
- Nov 5, 2026: Short sales 53.1%
- Nov 6, 2026: Short sales 39%
- Nov 9, 2026: Short sales 53.7%
- Nov 10, 2026: Short sales 38%
- Nov 11, 2026: Short sales 57.6%
- Nov 12, 2026: Short sales 55.3%
- Nov 13, 2026: Short sales 69.2%
- Nov 16, 2026: Short sales 55.6%
- Nov 17, 2026: Short sales 74%
- Nov 18, 2026: Short sales 66.3%
- Nov 19, 2026: Short sales 73.5%
- Nov 20, 2026: Short sales 60%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Invus Public Equities Advisors, LLCTenPercentOwnerDirectly10.85M
- Invus Global Management, LLCTenPercentOwnerDirectly9.25M
- Srinivas AkkarajuDirectorDirectly6.61M
- David HallalChief Executive OfficerDirectly1.84M
- Akshay VaishnawPresident of R&DDirectly630.5K
- Keith WoodsChief Operating OfficerDirectly620.1K
- Vikas SinhaChief Financial OfficerDirectly619.9K
- Jay T. BackstromCHIEF EXECUTIVE OFFICERDirectly312.0K
- Junlin HoGENERAL COUNSELDirectly241.5K
- Caryn ParlavecchioCHRODirectly169.1K
- Jing L. MarantzCHIEF MEDICAL OFFICERDirectly126.0K
- Kristina BurowDirectorDirectly114.7K
- Edward H MylesCOO & CFODirectly111.3K
- Mo QatananiCHIEF SCIENTIFIC OFFICERDirectly98.6K
- Erin MooreInterim PFO and PAODirectly82.6K
- Tracey SaccoChief Commercial OfficerDirectly71.8K
- Michael GilmanDirectorDirectly59.6K
- Katie PengDirectorDirectly34.3K
- Jeffrey S. FlierDirectorDirectly27.9K
- Richard BrudnickDirectorDirectly21.9K
- Joshua ReedDirectorDirectly20.5K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Invus Public Equities Advisors, LLCTenPercentOwner | 10.85M | – | Nov 25, 2024 | Form 4 |
| Invus Global Management, LLCTenPercentOwner | 9.25M | – | Dec 10, 2024 | Form 4 |
| Srinivas AkkarajuDirector | 6.61M | 525.6K | Oct 26, 2026 | Form 4 |
| David HallalChief Executive Officer | 1.84M | – | Sep 21, 2026 | Form 4 |
| Akshay VaishnawPresident of R&D | 630.5K | – | Apr 16, 2026 | Form 4 |
| Keith WoodsChief Operating Officer | 620.1K | – | Sep 24, 2026 | Form 4 |
| Vikas SinhaChief Financial Officer | 619.9K | – | Apr 16, 2026 | Form 4 |
| Jay T. BackstromCHIEF EXECUTIVE OFFICER | 312.0K | – | Feb 18, 2025 | Form 4 |
| Junlin HoGENERAL COUNSEL | 241.5K | – | Feb 17, 2026 | Form 4 |
| Caryn ParlavecchioCHRO | 169.1K | – | Feb 17, 2026 | Form 4 |
| Jing L. MarantzCHIEF MEDICAL OFFICER | 126.0K | – | Feb 17, 2026 | Form 4 |
| Kristina BurowDirector | 114.7K | – | Jul 1, 2026 | Form 4 |
| Edward H MylesCOO & CFO | 111.3K | – | Mar 10, 2025 | Form 4 |
| Mo QatananiCHIEF SCIENTIFIC OFFICER | 98.6K | – | Feb 23, 2026 | Form 4 |
| Erin MooreInterim PFO and PAO | 82.6K | – | Mar 24, 2025 | Form 4 |
| Tracey SaccoChief Commercial Officer | 71.8K | – | Apr 25, 2025 | Form 4 |
| Michael GilmanDirector | 59.6K | – | Jul 1, 2026 | Form 4 |
| Katie PengDirector | 34.3K | – | Jul 1, 2026 | Form 4 |
| Jeffrey S. FlierDirector | 27.9K | – | Jul 1, 2026 | Form 4 |
| Richard BrudnickDirector | 21.9K | – | Jun 4, 2026 | Form 4 |
| Joshua ReedDirector | 20.5K | – | Jul 1, 2026 | Form 4 |
A lower bound: it counts only the 21 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund1.16%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.73%
- IBBiShares Biotechnology ETFWeight in the fund0.41%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.35%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.20%
- IWMiShares Russell 2000 ETFWeight in the fund0.19%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.12%
- VXFVanguard Extended Market Index FundWeight in the fund0.06%
- VHTVanguard Health Care Index FundWeight in the fund0.06%
- FBCGFidelity Blue Chip Growth ETFWeight in the fund0.05%
19 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 242
- Q4 2025: Managers 274
- Q1 2026: Managers 277
- Q2 2026: Managers 306
Institutional investors by quarter
The fund managers holding SRRK, quarter by quarter, from Q2 2018 to Q2 2025, 29 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 306 managers held 139M shares, worth $7.6B. During the quarter 57 opened a position, 28 closed one, 125 added and 82 trimmed.
The largest holders, Q2 2026
- FMRIn the quarter+4.4%
- SirenIn the quarter-12%
- BlackRockIn the quarter+27%
- Samsara BiocapitalIn the quarter
- Price T Rowe AssociatesIn the quarter+9.5%
- Wellington Management GroupIn the quarter+0.1%
- Orbis Allan GrayIn the quarter+42%
- Vanguard Capital ManagementIn the quarter+23%
- State StreetIn the quarter+17%
- Redmile GroupIn the quarter-52%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| FMR | 18.00M | +4.4% | $990M |
| Siren | 9.58M | -12% | $527M |
| BlackRock | 9.49M | +27% | $522M |
| Samsara Biocapital | 6.90M | $379M | |
| Price T Rowe Associates | 6.79M | +9.5% | $374M |
| Wellington Management Group | 6.73M | +0.1% | $370M |
| Orbis Allan Gray | 5.93M | +42% | $326M |
| Vanguard Capital Management | 4.77M | +23% | $262M |
| State Street | 4.73M | +17% | $260M |
| Redmile Group | 4.31M | -52% | $237M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Scholar Rock's filings show?
Who buys and sells is one part of Scholar Rock's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have SRRK's insiders bought or sold?
From Jun 8, 2026 to Oct 27, 2026 Scholar Rock's insiders bought $12M and sold $923.1K of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold SRRK?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $101M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.